| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1862 | 2020 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 297 | 2021 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 176 | 2021 |
| Epidemiology of colorectal cancer in average risk adults 20–39 years of age: a population-based national study M Glover, E Mansoor, M Panhwar, S Parasa, GS Cooper Digestive diseases and sciences 64, 3602-3609, 2019 | 83 | 2019 |
| COVID-19 and Cancer Consortium NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study …, 2020 | 54 | 2020 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 48 | 2022 |
| Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study VS Koshkin, N Henderson, M James, D Natesan, D Freeman, A Nizam, ... Cancer 128 (6), 1194-1205, 2022 | 42 | 2022 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 41 | 2021 |
| Learning through a pandemic: the current state of knowledge on COVID-19 and cancer A Elkrief, JT Wu, C Jani, KT Enriquez, M Glover, MR Shah, HG Shaikh, ... Cancer discovery 12 (2), 303-330, 2022 | 35 | 2022 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 32 | 2023 |
| Changes in cancer management due to COVID-19 illness in patients with cancer in Northern California JTY Wu, DH Kwon, MJ Glover, S Henry, D Wood, DL Rubin, VS Koshkin, ... JCO oncology practice 17 (3), e377-e385, 2021 | 20 | 2021 |
| Influence of chronic inflammation on Bcl‑2 and PCNA expression in prostate needle biopsy specimens M Glover, S Soni, Q Ren, GT Maclennan, P Fu, S Gupta Oncology Letters 14 (4), 3927-3934, 2017 | 19 | 2017 |
| A systematic framework to rapidly obtain data on patients with cancer and COVID-19: CCC19 governance, protocol, and quality assurance M Abidi, DM Aboulafia, MK Accordino, JD Acoba, MS Ahluwalia, ... Cancer Cell 38 (6), 761-766, 2020 | 18 | 2020 |
| Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors T El Zarif, AH Nassar, GR Pond, TZ Zhuang, V Master, B Nazha, S Niglio, ... JNCI: Journal of the National Cancer Institute 115 (12), 1605-1615, 2023 | 13 | 2023 |
| Glace (M) G NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... Grothey, A, 2020 | 12 | 2020 |
| Patient-reported outcome measurement implementation in cancer survivors: a systematic review S Singhal, J Dickerson, MJ Glover, M Roy, M Chiu, T Ellis-Caleo, G Hui, ... Journal of Cancer Survivorship 18 (2), 223-244, 2024 | 9 | 2024 |
| Assessment of regional variability in COVID-19 outcomes among patients with cancer in the United States JE Hawley, T Sun, DD Chism, N Duma, JC Fu, NTN Gatson, S Mishra, ... JAMA network open 5 (1), e2142046-e2142046, 2022 | 9 | 2022 |
| Racial diversity and reporting in United States food and drug administration registration trials for thoracic malignancies from 2006 to 2020 RS Chiang, A Desai, MJ Glover, G Hui, KJ Ramchandran, H Wakelee, ... Cancer Investigation 41 (1), 43-47, 2023 | 4 | 2023 |
| Disparity of race reporting in US Food and Drug Administration drug approvals for urinary system cancers from 2006 to 2021. M Glover, G Hui, R Chiang, P Savage, J Krell, M Julve, P Grivas, ... BJU international 129 (2), 2022 | 3 | 2022 |
| Systemic anticancer therapy and thromboembolic outcomes in hospitalized patients with cancer and COVID-19 S Gulati, CY Hsu, S Shah, PK Shah, R Zon, S Alsamarai, J Awosika, ... JAMA oncology 9 (10), 1390-1400, 2023 | 2 | 2023 |
